Gynaecological Survey – Medical College, Nizhny Novgorod (Russia): Effectiveness of Treatment with Deta-AP devices
This survey was conducted under the supervision of Professor B.E. Sachob, beginning on 04/09/2009.
100 women were examined, aged 18 to 42 years suffering from Pelvic Inflammatory Disease (PID) associated with infections such chlamydia, mycoplasmas, ureoplasma, Cytomegalovirus, herpes and HPV – these women were divided into 3 groups:
   Use of Deta-AP only
   The use of Deta-AP along with prescription medications
   The use of only prescribed medications
The highest effectiveness of treatments was when the Deta-AP was combined with prescribed medications (87 – 92%) and 85% effectiveness when the Deta-AP alone was used.
When using only prescribed medications such as antibiotics and antivirals, the effectiveness dropped to 60 – 65%.
It appears that the Deta-AP can clearly compliment prescribed medications and increase their effectiveness, even though the Deta-AP used by itself can still help 85% of these PID infections.